The latest guidelines have not recommended medicines like ivermectin, favipiravir, and Doxycycline. Antivirals like Molnupiravir and monoclonal antibodies are also not included in the guidelines
An advisory council of the Ministry of Health (MoH) has proposed this ministry grant certificates of registration for conditional circulation of three medicines containing the active ingredient molnupiravir for COVID-19 treatment.